Fourth, because of the lack of more determinative equipment or facilities, such as genetic study, dopamine transporter uptake imaging, amyloid plaque imaging, CSF biomarkers, or pathological studies, the diagnosis of DLB, PDD, and AD was based only on clinical criteria. Here, SLC6A3 is linked to Alzheimer disease.